Deals
Pfizer CEO Still Hunting for Deals and Willing to Go Big
This article is for subscribers only.
Failing to buy AstraZeneca Plc with the drug industry’s largest-ever deal hasn’t stopped Pfizer Inc.’s Ian Read from looking far and wide for acquisitions.
“We continue to look at all types of business development, regardless of size, that we believe would add value to shareholders,” Read, the company’s chief executive officer, said today on a conference call after his company announced second-quarter results.